The bulk of coverage towards the top gaining stock sectors over the past year has focused understandably on technology, which has made huge strides, with semiconductors exceeding +60%. However, the ...

Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund XBI, a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 SPX by 9 ...

Frazier Life Sciences and Venrock Healthcare Capital Partners co-led Angitia Biopharmaceuticals' series D round. (iStock / Getty Images Plus) Angitia Biopharmaceuticals has unveiled its second ...

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) ETF is poised for a significant upward move, reflecting strong potential in the biotechnology sector. This ...

Each morning for eight weeks, Douley Olivier dragged himself out of bed at 5 a.m. to drop his girlfriend at work so he could drive her car across Dorchester to train as a lab technician in the ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Researchers are increasingly using AI and biotechnology tools to better understand the ...

The stock market's attention has been focused almost exclusively on artificial intelligence, semiconductors and a handful of megacap technology companies. Investors looking for value may find one of ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

U.K. pharmaceutical group GSK has entered an agreement to acquire U.S.-based specialist oncology biotech Nuvalent for $10.6 billion. The acquisition could help GSK offset a drop in revenue expected ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Research Scientist in Lab For years, public debate around U.S. dependence on China has ...

The field of biotechnology has always transformed cutting-edge science into life-changing medicines, but today that transformation is happening at a staggering pace. New discoveries are faster, ...

Biotech investing can feel a little bit like a Vegas sportsbook sometimes. Pick the company with the right drug trial and you could be swimming in profits. Miss that pick and you could easily see your ...